Introduction {#sec1-1}
============

Canine parvovirus (CPV) is one of the most common viruses in domestic dogs. It causes acute hemorrhagic gastroenteritis, leukopenia, nausea, diarrhea, and sometimes fatal myocarditis in young puppies \[[@ref1]\]. CPV belongs to the family *Parvoviridae*, subfamily *Parvovirinae*, and genus *Parvovirus*. It is a non-enveloped, icosahedral, linearized, and single-stranded DNA virus. The genome of CPV is approximately 5.2 kb in length. The virus encodes two nonstructural proteins (*NS1* and *NS2*) and three structural proteins (*VP1*, *VP2*, and *VP3*). The *VP2* capsid protein is the main capsid protein and plays an important role in the determination of the antigenicity and host range of CPV \[[@ref2]\]. CPV type 2 (CPV-2) was first identified in the USA in 1978 and was found to have spread worldwide in domestic and wild canid populations \[[@ref3]\]. CPV is genetically close to feline panleukopenia virus (FPV); however, CPV has at least seven amino acid differences from FPV which determine the canine or feline host range, such as amino acid positions 80 (Lys-Arg), 93 (Lys-Asn), 103 (Val-Ala), 232 (Val-Ile), 323 (Asp-Asn), 564 (Asn-Ser), and 568 (Ala-Gly) \[[@ref4]\].

The original CPV-2 was replaced worldwide by CPV-2a and CPV-2b in 1985. CPV-2a and CPV-2b have some nucleotide changes at the *VP2* gene compared to the original CPV-2. There are six amino acid differences at residues 87 (Met-Leu), 101 (Ile-Thr), 300 (Ala-Gly), 305 (Asp-Tyr), 375 (Asn-Asp), and 555 (Val-Ile) between CPV-2 and CPV-2a and six amino acid differences at residues 87 (Met-Leu), 101 (Ile-Thr), 300 (Ala-Gly), 305 (Asp-Tyr), 375 (Asn-Asp), and 426 (Asn-Asp) between CPV-2 and CPV-2b. The differences between CPV-2a and CPV-2b are the substitution of two amino acids in the *VP2* capsid protein, namely, Asn-426 in 2a (Asp-426 in 2b) and Ile-555 in 2a (Val-555 in 2b). Recently, the emergence of new CPV-2a and CPV-2b has been reported having an amino acid mutation at position 297 (Ser-Ala). Moreover, the new CPV-2a has a mutation at amino acid position 555 that changes isoleucine back to valine \[[@ref4]-[@ref8]\]. CPV-2c is a new CPV strain that has a glutamate substitution at the 426 residues of the *VP2* protein \[[@ref9]-[@ref11]\]. Recently, CPV-2c has been detected in Argentina \[[@ref12]\], Australia \[[@ref13]\], Italy \[[@ref10]\], Laos \[[@ref14]\], Spain \[[@ref6]\], Taiwan \[[@ref15]\], and Uruguay \[[@ref16]\]. According to the information above, CPV has a high mutation rate and has been dynamically evolving in many parts of the world. There is a growing concern about the severity and effectiveness of vaccine regarding the new mutant or genotype of CPV.

Molecular surveillance may be used as a tool for the detection of the new mutant, prediction of disease severity and providing the important data for the development of the better vaccine or the better diagnostic test in the future. Moreover, the knowledge of the current genotype of the CPV in Thailand is limited. This study aimed to investigate the current genotype of CPV circulating in Thailand and to determine the existence of CPV-2c and other CPV strains.

Materials and Methods {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

This study was approved by the Animal Ethics Committee of the Faculty of Veterinary Medicine, Kasetsart University, Thailand (ACKU62-VET-007).

Samples {#sec2-2}
-------

Eighty-five fecal samples were used in this study based on a positive result for CPV according to routine polymerase chain reaction (PCR) testing. In 2010 and 2018, 60 and 25 positive samples, respectively, were collected ([Table-1](#T1){ref-type="table"}). These fecal samples were collected from dogs that displayed either acute hemorrhagic diarrhea or diarrhea and nausea at the Veterinary Teaching Hospital, Kasetsart University, Rattanatibeth Referral Animal Hospital, Bangkok, Thailand, and the Amphawa Pet Hospital, Samut Songkhram, Thailand. These dogs were either vaccinated or unvaccinated and were aged from 1 month to 5 years. The fecal samples were stored at −80°C until used for DNA extraction.

###### 

Age of parvovirus-infected dogs, vaccination, year of sample collection, GenBank accession number, genotype of CPV, and amino acid at important position (NR=no report).

  No.   Sample        Amino acid position   CPV type   Previous vaccination   Age   GenBank accession number   Year of collection                                                                                     
  ----- ------------- --------------------- ---------- ---------------------- ----- -------------------------- -------------------- --- --- --- --- --- --- --- --- --- --- --- -------- ----- ----------- ---------- ------
  1     FPV-VT-2020   K                     M          N                      V     V                          F                    S   A   D   D   Y   Q   N   T   V   N   A   FPV      NR    1 years     MN270937   2018
  2     CPV-VT-1      R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    NR          KP715658   2010
  3     CPV-VT-7      R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    3 M         KP715659   2010
  4     CPV-VT-13     R                     L          N                      A     I                          F                    A   G   Y   N   I   Q   N   T   V   S   G   New 2a   No    3 M         KP715660   2010
  5     CPV-VT-14     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    2 M         KP715661   2010
  6     CPV-VT-30     R                     L          N                      A     I                          F                    A   G   Y   N   I   Q   N   T   V   S   G   New 2a   Yes   3 M         KP715662   2010
  7     CPV-VT-37     R                     L          N                      A     I                          F                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   Yes   2 M         KP715663   2010
  8     CPV-VT-39     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    5 M         KP715664   2010
  9     CPV-VT-40     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    2 M         KP715665   2010
  10    CPV-VT-42     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    1 M         KP715666   2010
  11    CPV-VT-45     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   Yes   2 M         KP715667   2010
  12    CPV-VT-51     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   Yes   6 M         KP715668   2010
  13    CPV-VT-58     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    2 M         KP715669   2010
  14    CPV-VT-61     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    3 M         KP715670   2010
  15    CPV-VT-62     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    \>3 M       KP715671   2010
  16    CPV-VT-71     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   Yes   5 M         KP715672   2010
  17    CPV-VT-81     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    4 M         KP715673   2010
  18    CPV-VT-82     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    2 M         KP715674   2010
  19    CPV-VT-83     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    3 M         KP715675   2010
  20    CPV-VT-87     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    2 M         KP715676   2010
  21    CPV-VT-88     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    3 M         KP715677   2010
  22    CPV-VT-89     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    1.5 M       KP715678   2010
  23    CPV-VT-92     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    3 M         KP715679   2010
  24    CPV-VT-93     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    3 M         KP715680   2010
  25    CPV-VT-97     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    3 M         KP715681   2010
  26    CPV-VT-103    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   No    \>3 M       KP715682   2010
  27    CPV-VT-109    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    NR          KP715683   2010
  28    CPV-VT-115    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    NR          KP715684   2010
  29    CPV-VT-138    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    3 M         KP715685   2010
  30    CPV-VT-139    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    3.5 M       KP715686   2010
  31    CPV-VT-0561   R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    NR          MN270938   2018
  32    CPV-VT-1377   R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    NR          MN270939   2018
  33    CPV-VT-2097   R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    2 M         MN270940   2018
  34    CPV-VT-2098   R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    2 M         MN270941   2018
  35    CPV-VT-2961   R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   N   A   V   S   G   New 2a   NR    1 M         MN270942   2018
  36    CPV-VT-3      R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    2 years     KP715687   2010
  37    CPV-VT-12     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   Yes   7 M         KP715688   2010
  38    CPV-VT-18     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    2 M         KP715689   2010
  39    CPV-VT-28     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   Yes   3 M         KP715690   2010
  40    CPV-VT-43     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   NR    1 years     KP715691   2010
  41    CPV-VT-49     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   Yes   4 M         KP715692   2010
  42    CPV-VT-53     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   A   V   S   G   New 2b   No    2 M         KP715693   2010
  43    CPV-VT-54     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    2 M         KP715694   2010
  44    CPV-VT-56     R                     L          N                      A     I                          Y                    A   G   Y   N   Y   Q   D   T   V   S   G   New 2b   No    5 M         KP715695   2010
  45    CPV-VT-65     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    NR          KP715696   2010
  46    CPV-VT-66     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    2 years     KP715697   2010
  47    CPV-VT-68     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    4 M         KP715698   2010
  48    CPV-VT-74     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    NR          KP715699   2010
  49    CPV-VT-75     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    2 M         KP715700   2010
  50    CPV-VT-80     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    4 M         KP715701   2010
  51    CPV-VT-84     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    4 M         KP715702   2010
  52    CPV-VT-86     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    5 M         KP715703   2010
  53    CPV-VT-90     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   Yes   6 M         KP715704   2010
  54    CPV-VT-99     R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    5 M         KP715705   2010
  55    CPV-VT-101    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    1 M         KP715706   2010
  56    CPV-VT-106    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   NR    NR          KP715707   2010
  57    CPV-VT-108    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   A   V   S   G   New 2b   NR    NR          KP715708   2010
  58    CPV-VT-114    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   NR    NR          KP715709   2010
  59    CPV-VT-120    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    3 M         KP715710   2010
  60    CPV-VT-121    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    2 M         KP715711   2010
  61    CPV-VT-123    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    8 M         KP715712   2010
  62    CPV-VT-129    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    1.5 years   KP715713   2010
  63    CPV-VT-135    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    NR          KP715714   2010
  64    CPV-VT-142    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   NR    1 M         KP715715   2010
  65    CPV-VT-143    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   T   V   S   G   New 2b   No    4 M         KP715716   2010
  66    CPV-VT-148    R                     L          N                      A     I                          Y                    A   G   Y   N   I   Q   D   A   V   S   G   New 2b   NR    2 M         KP715717   2010
  67    CPV-VT-0861   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    1 M         MN270943   2018
  68    CPV-VT-0937   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    NR          MN270944   2018
  69    CPV-VT-1161   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    11 M        MN270945   2018
  70    CPV-VT-1261   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    6 M         MN270946   2018
  71    CPV-VT-1361   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    4 M         MN270947   2018
  72    CPV-VT-1373   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    NR          MN270948   2018
  73    CPV-VT-1374   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    NR          MN270949   2018
  74    CPV-VT-1375   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    NR          MN270950   2018
  75    CPV-VT-1383   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    NR          MN270951   2018
  76    CPV-VT-1661   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    1 years     MN270952   2018
  77    CPV-VT-2016   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    2 M         MN270953   2018
  78    CPV-VT-2018   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    3 M         MN270954   2018
  79    CPV-VT-2019   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    3 years     MN270955   2018
  80    CPV-VT-2021   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    7 M         MN270956   2018
  81    CPV-VT-2388   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    3 M         MN270957   2018
  82    CPV-VT-2389   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    5 M         MN270958   2018
  83    CPV-VT-2391   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    2.5 years   MN270959   2018
  84    CPV-VT-2461   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    3 M         MN270960   2018
  85    CPV-VT-3761   R                     L          N                      A     I                          Y                    A   G   Y   N   I   R   E   T   V   S   G   2c       NR    21 days     MN270961   2018

CPV=Canine parvovirus, FPV=Feline panleukopenia virus

DNA extraction and PCR {#sec2-3}
----------------------

DNA was extracted from the fecal samples using the acid guanidinium thiocyanate-phenol-chloroform extraction method. A set of primers was designed to amplify the whole *VP2* gene: F (5'-ATG AGT GAT GGA GCA GTT CA) and R (5'-TTA ATA TAA TTT TCT AGG TGC TAG TTG). The PCR mixture (25 µl) was composed of 1× buffer (20 mM Tris-HCl \[pH 8.4\], 50 mM KCl~2~), 0.2 mM dNTPs, 2.5 mM MgCl~2~, 100 pmol of each of the forward and reverse primers, 1 unit Taq DNA polymerase (Invitrogen, Carlsbad, CA, USA), and 2.5 µl of DNA template to give a total volume of 25 µl. After an initial denaturing at 94°C for 5 min, the amplification was performed using 35 cycles at 94°C for 40 s, annealing at 50°C for 40 s, and extension at 72°C for 90 s, and a final extension at 72°C for 10 min. The expected PCR products were 1755 bps in size. The PCR products were analyzed using 1% agarose gel electrophoresis at 100 V for 30 min and visualized under ultraviolet illumination. The PCR products were purified using an UltraClean^®^15 DNA Purification Kit (MO BIO Laboratories, Inc., Carlsbad, CA, USA) and cloned into plasmid pGEM-T Easy (Promega Corporation, Madison, WI, USA). The sequences of the cloned full-length *VP2* were determined at First BASE Laboratories Sdn Bhd, Selangor, Malaysia.

Analysis and phylogenetic construction of full-length VP2 gene of CPVs {#sec2-4}
----------------------------------------------------------------------

The nucleotide sequences were translated into amino acid and multiple alignments of the amino acid sequences using the Bioedit biological sequence alignment editor computer package (version 7.1.3; Ibis Biosciences, Carlsbad, CA, USA). The phylogenetic analysis was constructed from the amino acid sequences of all 85 samples in this study and other full-length *VP2* sequences obtained from the GenBank database ([Table-2](#T2){ref-type="table"}) using the MEGA program (version 7.0, The Biodesign Institute, Tempe, AZ, USA) with the neighbor-joining method and running 1000 replicates in the bootstrap. Bayesian phylogenetic analysis was also performed for more extensive amino acids analysis to analyze the selective pressures on certain amino acids using mixed model analysis. The phylogenetic tree was created by MrBayes version 3.2.6 (<https://nbisweden.github.io/MrBayes/download.html>) \[[@ref17]\]. The tree was viewed using FigTree software version 1.4.3 (<http://tree.bio.ed.ac.uk/software/figtree/>).

###### 

GenBank accession numbers of CPV used in phylogenetic tree construction.

  Order   Origin      GenBank accession number   Year of collection   Genetic type
  ------- ----------- -------------------------- -------------------- --------------
  1       China       MF467224                   2015                 2a
  2       China       FJ435343                   2008                 2a
  3       China       FJ435345                   2008                 2a
  4       China       GU380304                   2009                 2a
  5       China       GU569936                   2008                 2a
  6       France      DQ026002                   \-                   2a
  7       India       KX469433                   2015                 2a
  8       Italy       FJ005259                   2008                 2a
  9       Singapore   KY083098                   2014                 2a
  10      Thailand    GQ379047                   2009                 2a
  11      Thailand    GQ379045                   2009                 2a
  12      Thailand    GQ379046                   2009                 2a
  13      Uruguay     KM457139                   2011                 2a
  14      Uruguay     JF906788                   2010                 2a
  15      Vietnam     LC214970                   2013                 2a
  16      China       GU569937                   2002                 2b
  17      China       KF482468                   2009                 2b
  18      China       GU569938                   2002                 2b
  19      China       GU569944                   2002                 2b
  20      China       JQ743891                   2010                 2b
  21      Italy       FJ005263                   2005                 2b
  22      Thailand    FJ869123                   2008                 2b
  23      Thailand    FJ869124                   2008                 2b
  24      Vietnam     AB120724                   2013                 2b
  25      USA         JX475261                   2010                 2b
  26      Argentina   KM236569                   2013                 2c
  27      China       KT162005                   2014                 2c
  28      China       KT162016                   2014                 2c
  29      China       KP260509                   2014                 2c
  30      China       KY937641                   2016                 2c
  31      Croatia     KP859576                   2014                 2c
  32      Ecuador     KF149984                   2012                 2c
  33      Germany     FJ005202                   1997                 2c
  34      Germany     FJ005204                   1999                 2c
  35      Greece      GQ865518                   2008                 2c
  36      Indonesia   LC216905                   2013                 2c
  37      Italy       HQ025913                   2010                 2c
  38      Singapore   KY083092                   2014                 2c
  39      Uruguay     KM457112                   2008                 2c
  40      \-          M74849                     \-                   2b
  41      \-          M24003                     \-                   2a
  42      \-          M38245                     \-                   2
  43      \-          FJ405225                   \-                   FPV

CPV=Canine parvovirus, FPV=Feline panleukopenia virus

Results {#sec1-3}
=======

Thirty-nine and nine samples out of 85 positive samples were from non-vaccinated and vaccinated dogs, respectively. The other 37 positive samples did not have a history of vaccination. The youngest CPV-infected dog was aged 21 days, and the oldest was 3 years. The youngest age of positive vaccinated dogs was 2 months; however, the individual histories of booster vaccination for these positive, vaccinated dogs were not available ([Table-1](#T1){ref-type="table"}).

For the 2010 data, the amino acid sequences analysis revealed that 29 samples were new CPV-2a and 31 samples were new CPV-2b due to amino acids substitution at position 297 (Ser-Ala) ([Table-1](#T1){ref-type="table"}). The number of positive samples for new CPV-2a and new CPV-2b was nearly equal in 2010. For 2018, 5 new CPV-2a, 19 CPV-2c, and 1 FPV were found, but CPV-2b was not detected ([Table-3](#T3){ref-type="table"}). In this study, most of the CPV had amino acid substitution at positions 324 and 440. Eighty-three CPV had 324 (Tyr-Ile) substitution due to a T-to-A transversion at nucleotide 970 and an A-to-T transversion at nucleotide 971 with the exception of 1 sample of new CPV-2b in 2010 (CPV-VT 56) ([Figure-1](#F1){ref-type="fig"}). Thirty-two out of 34 new CPV-2a and three out of 31 new CPV-2b (CPV-VT 53, CPV-VT 108, and CPV-VT 148) had 440 (Thr-Ala) substitution due to an A-to-G transition at nucleotide 1318 ([Table-1](#T1){ref-type="table"}). The new CPV-2a in this study was closely related to CPV-2a from Thailand in 2009 (GQ379045, GQ379046, and GQ379047), and from Uruguay in 2010 and 2011 (JF906788 and KM457139), China in 2015 (MF467224), India in 2015 (KX469433), Singapore in 2014 (KY083098), and Vietnam in 2013 (LC214970) (Figures[-2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}) due to similar amino acids at positions 267 (Tyr), 324 (Ile), and 440 (Ala). However, two new CPV-2a (CPV-VT 13 and 30) were closely related to new CPV-2a from China in 2008 (FJ435343, FJ435345, GU380304, and GU569936) (Figures[-2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}) due to similar amino acids at positions 267 (Phe), 324 (Ile), and 440 (Thr). All CPVs in this study had 267 (Phe-Tyr) due to an A-to-T transversion at nucleotide 800 substitution except for the two new CPV-2a samples (CPV-VT 13 and 30) that did not have 440 (Thr-Ala) substitution and one new CPV-2a (CPV-VT 37) that had substitution at position 440. All CPV-2a samples had valine at position 555.

###### 

Number of parvoviruses found in each year.

  Year    Type of parvoviruses                  
  ------- ---------------------- ---- ---- ---- ----
  2010    0                      29   31   0    60
  2018    1                      5    0    19   25
  Total   1                      34   31   19   85

CPV=Canine parvovirus, FPV=Feline panleukopenia virus

![Amino acid comparison of *VP2* gene of CPV-2a: CPV-VT13 (T440), CPV-VT93 (A440), CPV-VT2097, CPV-2b: CPV-VT56 (324Y), CPV-VT90 (440T), and CPV-VT108 (440A), CPV-2c: CPV-VT2391, FPV: FPV-VT2020 in this study, with reference strains FPV (FJ405225), CPV-2 (M38245), CPV-2a (M24003) and CPV-2b (M74849) and other isolates from other parts of the world. CPV=Canine parvovirus, FPV=Feline panleukopenia virus.](Vetworld-13-245-g001){#F1}

![Phylogenetic tree constructed from 80 amino acid sequences of the *VP2* gene of canine parvovirus (CPV) and feline panleukopenia virus (FPV) in this study and other CPV and FPV sequences obtained from GenBank database using the neighbor-joining method and bootstrap analysis performed with 1000 trials. Drawn using MEGA version. **■**=Samples collected in 2018 and **▲**=Samples collected in 2010.](Vetworld-13-245-g002){#F2}

![Phylogenetic tree constructed from 80 amino acids of the *VP2* gene of canine parvovirus (CPV) and feline panleukopenia virus (FPV) in this study and other CPV and FPV sequences obtained from GenBank database using MrBayes version 3.2.6 with Markov chain Monte Carlo, with 5 million generations. Node values (in percentages) indicate posterior clade probabilities. Vertical bars indicate clades of CPV in each group, A=CPV-2c in Europe and South America, B=new CPV-2b in this study, C=CPV-2c in this study, and Asia, D=new CPV-2b that has alanine at amino acid position 440, F=new CPV-2a in this study.](Vetworld-13-245-g003){#F3}

In contrast to new CPV-2a in this study, all new CPV-2b in this study was distanced from CPV-2b reported previously in Thailand in 2008 (FJ869123 and FJ869124) and Europe in 2005 (FJ005263) (Figures[-2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}) because of the amino substitution at position 324 (Tyr-Ile). However, three new CPV-2b (CPV-VT 53, CPV-VT 108, and CPV-VT 148) were closely related to the new CPV-2b from China in 2010 (JQ743891) and were also closely related to a cluster of new CPV-2a. These three CPV-2b distanced from the other new CPV-2b in this study (Figures[-2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}) due to amino substitution at positions 324 (Tyr-Ile) and 440 (Thr-Ala). Nineteen CPV-2c in this study had amino acids substitution at positions 267 (Phe-Tyr), 324 (Tyr-Ile), and 370 (Gln-Arg) due to an A-to-G transition at nucleotide 1109 and a G-to-T transversion at nucleotide 1110. CPV-2c in this study was closely related to CPV-2c from Asia including China in 2014 and 2016 (KP260509, KT162005, KT162016, and KY937641), Indonesia in 2013 (LC216905), and Singapore in 2014 (KY083092) due to these three amino acids substitution (Figures[-2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}), but distanced from the CPV-2c in Europe and South America. Interestingly, one dog with clinical signs of diarrhea was positive for FPV. The six amino acids (at 80, 103, 232, 323, 564, and 568) out of the seven amino acids which determine the canine or feline host range were similar to the reference FPV; however, there was an amino acid substitution at position 93 (Lys-Asn). According to this amino acid substitution, FPV in this study was in the different clades compared to the reference FPV (Figures[-2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

Discussion {#sec1-4}
==========

The number of samples positive for new CPV-2a and 2b circulating in central Thailand in 2010 was approximately equal. This result contrasted with a study in Thailand (data collected between 2003 and 2008) in which the predominant genotype in central Thailand was CPV-2a \[[@ref11]\]. Interestingly, the majority CPV genotype in 2018 was CPV-2c, but new CPV-2b was not found. This study showed that CPV-2c had become the predominant genotype during the year 2018 in Thailand. Besides of t he diminishing of CPV-2b, there was only one amino acid difference at position 426 between CPV-2b and CPV-2c but there were two amino acids differences at positions 426 and 440 between CPV-2a and CPV-2c. Thus, the emergence of CPV-2c in Thailand might have derived from the new CPV-2b (2010) that had a mutation at position 426 (Asp-Glu).

From the previous study in Thailand (2003-2009), both CPV-2a and CPV-2b had alanine at amino acid position 297 \[[@ref11]\]. According to this finding, CPV-2a and CPV-2b (2003-2009) were new CPV-2a and new CPV-2b. However, most of the CPV in this study had additional amino acid substitution at position 324 (Tyr-Ile), except for 1 CPV-2b (CPV-VT 56). Thus, the new CPV-2b (2010) was different from the new CPV-2b in Thailand (2003-2009) and Europe (2005). The amino acid substitution at residue 324 (Tyr-Ile) was also reported in Brazil \[[@ref18]\], China \[[@ref19]\], Hungary \[[@ref20]\], India \[[@ref21],[@ref22]\], Italy \[[@ref23]\], Nigeria \[[@ref24]\], South Korea \[[@ref25]\], Taiwan \[[@ref1],[@ref15]\], and Uruguay \[[@ref26]\]. According to the above, amino acid position 324 has been shown to undergo a strong positive selection in the parvovirus of all carnivores \[[@ref27]\]. Amino acid position 324 was also adjacent to the critical amino acid position 323 that has been known to control canine cell infection. The changes in the region of the capsid surface around *VP2* residue 300, within a raised region on the shoulder of the three-fold spike of the capsid, have been shown to influence the binding of the virus to the canine TfR \[[@ref28]-[@ref30]\]. This change may influence the interactions with their various host receptors and may be expected to result in an increased host range.

Moreover, most of the current new CPV-2a had alanine at amino acid position 440; however, most of the new CPV-2b still had threonine. Amino acid substitution at position 440 (Thr-Ala) was also reported in the previous studies in China \[[@ref19]\], India \[[@ref21],[@ref22]\], Nigeria \[[@ref24],[@ref31]\], Pakistan \[[@ref32]\], South Africa \[[@ref33]\], South Korea \[[@ref25]\], and Uruguay \[[@ref26]\]. Amino acid position 440 is also important because it is located at the top of the three-fold spike, the main antigenic site of the virus \[[@ref34],[@ref35]\]. Interestingly, this mutation was not detected in a previous study in Thailand \[[@ref11]\]. In the current study, two new CPV-2a (CPV-VT13 and 30) had phenylalanine and threonine at amino acid positions 267 and 440 similar to CPV-2a in 2003-2004 as reported in the previous study in Thailand, but these two strains had isoleucine at amino acid position 324 as seen in CPV-2a in 2008-2009 and new CPV-2a in this study \[[@ref11]\]. However, most of the current new CPV-2a in the current study had tyrosine and alanine at positions 267 and 440, as seen in CPV-2a in 2008-2009, respectively. A CPV-2a (CPV-VT37) had phenylalanine and isoleucine at positions 267 and 324 similar to CPV-2a in 2003-2004 but had alanine at amino acid position 440 as seen in CPV-2a in 2008-2009 and new CPV-2a in this study. CPV-VT13, 30, and 37 might represent the transition evolution of the original new CPV-2a to the current new CPV-2a. CPV-2b (CPV-VT56) had similar amino acids at amino acid positions 267, 324, 426, and 440 (phenylalanine, tyrosine, aspartic acid, and threonine, respectively), as reported in the previous study in Thailand \[[@ref11]\]. However, new CPV-2b in this study had isoleucine at amino acid 324. Thus, CPV-VT56 might also represent the transition evolution of the original new CPV-2b in the current new CPV-2b.

The CPV-2c in this study was similar to CPV-2c in Asia, such as in China \[[@ref36]\], Laos \[[@ref14]\], and Taiwan \[[@ref15],[@ref37]\] due to amino acid substitution at amino acid positions 267 (Tyr), 324 (Ile), and 370 (Arg). CPV-2c in this study differs from CPV-2c in Europe and South America at three amino acid positions (Phe267Tyr, Tyr324Ile, and Gln370Arg). The amino acid substitution at position 440 (Thr-Ala) has been found in Argentina, but this change was not found in this study \[[@ref12]\]. Interestingly, FPV was found in a dog that had clinical signs of diarrhea. This FPV sample had an amino acid substitution at position 93 (Lys-Asn). The amino acid at position 93 is important because it is one of the amino acids that determine the canine host range \[[@ref38]\]. FPV infection in dogs has also been reported in Pakistan \[[@ref39]\]. These findings demonstrated that parvoviruses in Thailand have been dynamically evolving as those in the other part of the world \[[@ref40],[@ref41]\]. This mutation rate is as high as seen in RNA viruses \[[@ref41]\]. The rapid mutation of CPV has resulted in growing concern about the effectiveness of vaccines regarding the new mutant or genotype of CPV. Molecular surveillance of CPV is crucial for the prediction of disease severity and may be important for the development of more effective vaccines or diagnostic tests in the future.

Conclusion {#sec1-5}
==========

Two genotypes of CPV (new CPV-2a and CPV-2c) are circulating in Central Thailand and the predominant circulating genotype of CPV has been changed from CPV-2a in the past to CPV-2c at present. Currently, CPV-2b has not been found in Central Thailand. The current new CPV-2a circulating in Thailand has amino acid substitutions at positions 324 (Tyr-Ile) and 440 (Thr-Ala). FPV was found in a dog that had acute diarrhea; however, the importance of this finding remains to be determined. Our results provided additional information on the dynamic evolution of CPV in Thailand, which is following the same evolutionary trend observed in the others part of the world.
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